BTIG analyst Vincent Caintic updated the firm's stance on American Express (NYSE:AXP) shares, raising the price target to ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a decline, ending the day at $12.82 which represents a decrease of $-0.36 or -2.73% from the prior close of $13.18. The stock opened at $13.32 and touched ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...

In terms of valuation, Akebia Therapeutics Inc’s market capitalization stands at $519.27 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However ...

CAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASHUA, N.H., Jan.

BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was disappointed by the company’s comments around higher ...

SoFi (SOFI) surpassed analyst expectations in fourth quarter revenue and adjusted earnings per share (EPS), but its stock is ...